Cancer-related networks: a help to understand, predict and change malignant transformation.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Seminars in Cancer Biology

• Publication date

  2013-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.semcancer.2013.06.011PMID 23831276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evolutionary aspects of cancer resistance.

  2014cited by this paper
• Network-based strategies can help mono- and poly-pharmacology drug discovery: a systems biology view.

  2014cited by this paper
• Novel signatures of cancer‐associated fibroblasts

  2013cited by this paper
• Predicting cancer drug mechanisms of action using molecular network signatures.

  2013cited by this paper
• Understanding genomic alterations in cancer genomes using an integrative network approach.

  2013cited by this paper
• A colorectal cancer classification system that associates cellular phenotype and responses to therapy

  2013cited by this paper
• SignaLink 2 – a signaling pathway resource with multi-layered regulatory networks

  2013cited by this paper
• Understanding cancer mechanisms through network dynamics.

  2012cited by this paper
• Rigidity and flexibility of biological networks

  2012cited by this paper
• The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth

  2012cited by this paper
• Defining principles of combination drug mechanisms of action

  2012cited by this paper
• System level mechanisms of adaptation, learning, memory formation and evolvability: the role of chaperone and other networks.

  2012cited by this paper
• Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review

  2012cited by this paper
• Constructing structural networks of signaling pathways on the proteome scale.

  2012cited by this paper
• On the intrinsic inevitability of cancer: from foetal to fatal attraction.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Prosperity is associated with instability in dynamical networks.

  2011cited by this paper
• Dynamics and control of state-dependent networks for probing genomic organization

  2011cited by this paper
• Principles and strategies for developing network models in cancer.

  2011cited by this paper
• High‐throughput live‐cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts

  2011cited by this paper
• Allo-network drugs: harnessing allostery in cellular networks.

  2011cited by this paper
• PathWave: discovering patterns of differentially regulated enzymes in metabolic pathways

  2010cited by this paper
• Uniformly curated signaling pathways reveal tissue-specific cross-talks and support drug target discovery

  2010cited by this paper
• Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents

  2010cited by this paper
• Proof of Concept: Network and Systems Biology Approaches Aid in the Discovery of Potent Anticancer Drug Combinations

  2010cited by this paper
• Identification of high-quality cancer prognostic markers and metastasis network modules

  2010cited by this paper
• A mammalian functional-genetic approach to characterizing cancer therapeutics.

  2010cited by this paper
• Allosteric Regulation of Glycogen Synthase Kinase 3β: A Theoretical Study†

  2010cited by this paper
• Signal transduction networks in cancer: quantitative parameters influence network topology.

  2010cited by this paper
• Genetic analysis of complex disease--a roadmap to understanding or a colossal waste of money.

  2010cited by this paper
• Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective.

  2009cited by this paper
• Analyzing the regulation of metabolic pathways in human breast cancer

  2009cited by this paper
• Anti-apoptotic mechanisms of drug resistance in cancer.

  2009cited by this paper
• Flux balance analysis of primary metabolism in Chlamydomonas reinhardtii

  2009cited by this paper
• Network analyses in systems pharmacology

  2009cited by this paper
• Creative elements: network-based predictions of active centres in proteins and cellular and social networks.

  2008cited by this paper
• Regulation of cell growth by autophagy

  2008cited by this paper
• PRISM: protein-protein interaction prediction by structural matching.

  2008cited by this paper
• Mediators of vascular remodelling co-opted for sequential steps in lung metastasis

  2007cited by this paper
• Global topological features of cancer proteins in the human interactome

  2006cited by this paper
• Cancer: a Systems Biology disease.

  2006cited by this paper
• Cancer progression: The ultimate challenge

  1989cited by this paper
• Differentiation of malignant to benign cells.

  1971cited by this paper
• Homeostasis and Differentiation in Random Genetic Control Networks

  1969cited by this paper

• Cellular signaling pathways as plastic, proto-cognitive systems: Implications for biomedicine

  2023cites this paper
• What Are the Reasons for Continuing Failures in Cancer Therapy? Are Misleading/Inappropriate Preclinical Assays to Be Blamed? Might Some Modern Therapies Cause More Harm than Benefit?

  2022cites this paper
• The systemic hallmarks of cancer

  2020cites this paper
• Understanding cancer complexome using networks, spectral graph theory and multilayer framework

  2017cites this paper
• From cytoskeletal dynamics to organ asymmetry: a nonlinear, regulative pathway underlies left–right patterning

  2016cites this paper
• Fuzzy-CA model for an in-silico cancer cell line: A journey from simple cellular pattern to an emergent complex behavior

  2016cites this paper
• From cytoskeletal dynamics to organ asymmetry: a non-linear, regulative pathway underlies left-right patterning

  2016cites this paper
• Future perspectives for mTOR inhibitors in renal cell cancer treatment.

  2015cites this paper
• Increased signaling entropy in cancer requires the scale-free property of protein interaction networks

  2015cites this paper
• Modern temporal network theory: a colloquium

  2015cites this paper
• Cytokinome profile evaluation in patients with hepatitis C virus infection.

  2014cites this paper
• Structural Pathways of Cytokines May Illuminate Their Roles in Regulation of Cancer Development and Immunotherapy

  2014cites this paper
• Simulating tumor microenvironment: changes in protein expression in an in vitro co-culture system

  2014cites this paper
• Therapy resistance mechanisms in Ewing’s sarcoma family tumors

  2014cites this paper
• Changes of microenvironment in an in vitro co-culture system

  2014cites this paper
• Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential Mechanism: network models, novel therapeutic target strategies, and the contributions of hypoxia, inflammation and cellular senescence.

  2013cites this paper